mRNA and protein expression of FGF-1, FGF-2 and their receptors in the porcine umbilical cord during pregnancy

Folia Histochemica et Cytobiologica

Volumn 48, Issue 4, 2010, Pages 572-580

  Chrusciel, M ^a   Rekawiecki, R ^a   Ziecik, A J ^a   Andronowska, A ^a  

^a INSTITUTE OF ANIMAL REPRODUCTION AND FOOD RESEARCH   (Poland)

Author keywords

FGF; FGFR; Pig; Pregnancy; Umbilical cord

Indexed keywords

FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; MESSENGER RNA;

AMNION CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; MYOFIBROBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PREGNANCY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SWINE; TUNICA MEDIA; UMBILICAL CORD; UMBILICAL CORD BLOOD FLOW;

SUIDAE; SUS;

EID: 79958061545     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.2478/v10042-010-0073-4     Document Type: Article

References (50)

1. Chruoeciel M, Postek A, Andronowska A. Histological analyses of the porcine umbilical cord. Med Weter. 2008;64(4B):602-607 (In polish).
2. Harris DT, Rogers I. Umbilical cord blood: a unique source of pluripotent stem cells for regenerative medicine. Curr Stem Cell Res Ther. 2007;2:301-309.
3. Halasa M, Baskiewicz-Masiuk M, Dabkowska E, Machalinski B. An efficient two-step method to purify very small embryonic-like (VSEL) stem cells from umbilical cord blood (UCB). Folia Histochem Cytobiol. 2008;46: 239-243.
4. Sobolewski K, Bañkowski E, Chyczewski L, Jaworski S. Collagen and glycosaminoglycans of Wharton's jelly. Biol Neonate. 1997;71:11-21.
5. Franc S, Rousseau JC, Garrone R, van der Rest M, Morami-Ameli M. Microfibrillar composition of umbilical cord matrix: characterization of fibrillin, collagen VI and intact collagen V. Placenta. 1998;19:95-104.
6. Takechi K, Kuwabara Y, Mizuno M. Ultrastructural and immunohistochemical studies of Wharton's jelly umbilical cord cells. Placenta. 1993;14:235-245.
7. Nanaev AK, Kohnen G, Milovanov AP, Domogatsky SP, Kaufmann P. Stromal differentiation and architecture of the human umbilical cord. placenta 1997;18:53-64.
8. Randall GCB. Form and development of the umbilical cord in pigs and their association with delivery of viable pigs. Am J Vet Res. 1989;50:1512-1515.
9. Randall GCB. Observations on parturition in the sow. II. Factors influencing stillbirth and prenatal mortality. Vet Rec. 1972;90:183-186.
10. Randall GCB. Studies on the effect of acute asphyxia on the fetal pig in utero. Biol Neonate. 1979;36:63-69.
11. Svendsen J, Svendsen LS, Bengtsson A-C. Reducing perinatal mortality in pigs. In: Morrow DA, ed. Current therapy in theriogenology. 2end edition. Philadelphia, WB Saunders Co; 1986:939-946.
12. Basilico C, Moscatelli D. The FGF family of growth factors and oncogenes. Adv Cancer Res. 1992;59:115-165.
13. Powers CJ, McLeskey SW, Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer. 2000;7:165-197.
14. Lee PL, Johnson DE, Cousens LS, Fried VA, Williams LT. Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. Science. 1989;245:57-60.
15. Johnson DE, Lu J, Chen H, Werner S, Williams LT. The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain. Mol Cell Biol. 1991;11:4627-4634.
16. Avivi A, Yayon A, Givol D. A novel form of FGF receptor-3 using an alternative exon in the immunoglobulin domain III. FEBS Let. 1993;330:249-252.
17. Chellaiah AT, McEwen DG, Werner S, Xu J, Ornitz DM. Fibroblast growth factor receptor (FGFR) 3. J Biol Chem. 1994;269:11620-11627.
18. Orr-Urtreger A, Bedford MT, Burakova T, Arman E, Zimmer Y, Yayon A, Givol D, Lonai P. Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev Biol. 1993;158(2):475-486.
19. Ferriani RA, Ahmed A, Sharkey A, Smith SK. Co-localization of acidic and basic fibroblast growth factor (FGF) in human placenta and the cellular effects of bFGF in trophoblast cell line JEG-3. Growth Factors. 1994;10:259-268.
20. Zheng J, Vagnoni KE, Bird IM, Magness RR. Expression of basic fibroblast growth factor, endothelial mitogenic activity, and angiotensin II type-1 receptor in the ovine placenta during the third trimester of pregnancy. Biol Reprod. 1997;56:1189-1197.
21. Sobolewski K, Małkowski A, Bañkowski E, Jaworski S. Wharton's jelly as a reservoir of peptide growth factors. Placenta. 2005;26:747-752.
22. Malkowski A, Sobolewski K, Jaworski S, Bankowski E. FGF binding by extracellular matrix components of Wharton's jelly. Acta Biochim Pol. 2007;54:357-363
23. Spagnuolo-Weaver M, Fuerst R, Campbell ST, Meehan BM, McNeilly F, Adair B, Allan G. A fluorimeter-based RT-PCR method for the detection and quantitation of porcine cytokines. J Immunol Methods. 1999;230:19-27.
24. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem.1976;72:248-254.
25. Adams EJ, Green JA, Clark AH, Youngson JH. Comparison of different scoring systems for immunohistochemical staining. J Clin pathol. 1999;52:75-77.
26. Cattini PA, Nickel B, Bock M, Kardami E. Immunolocalization of Basic fibroblast growth factor (bFGF) in growing and growth-inhibited placenta cells: a possible role for bFGF in placenta cell development. Placenta. 1991;12:341-352.
27. Shams M, Ahmed A. Localization of mRNA for basic fibroblast growth factor in human placenta. Growth Factors. 1994;11:105-111.
28. Wang D. Discrepancy between mRNA and protein abundance: insight from information retrieval process in computers. Comput Biol Chem. 2008;32:462-468.
29. Le Roch KG, Johnson JR, Florens L, Zhou Y, Santrosyan A, Grainger M, Yan SF, Williamson KC, Holder AA, Carucci DJ, Yates JR 3rd, Winzeler EA. Global analysis of transcript and protein levels across the Plasmodium falciparum life cycle. Genome Res. 2004;11:2308-2318.
30. Griffin TJ, Gygi SP, Ideker T, Rist B, Eng J, Hood L, Aebersold R. Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol Cell Proteomics. 2002;1:323-333.
31. Tian Q, Stepaniants SB, Mao M, Weng L, Feetham MC, Doyle MJ, Yi EC, Dai H, Thorsson V, Eng J, Goodlett D, Berger JP, Gunter B, Linseley PS, Stoughton RB, Aebersold R, Collins SJ, Hanlon WA, Hood LE. Integrated genomic and proteomic analyses of gene expression in Mammalian cells. Mol Cell proteomics. 2004;3: 960-969.
32. Edmondson SR, Thumiger SP, Werther GA, Wraight CJ. Epidermal homeostasis: the role of the growth hormone and insulin-like growth factor systems. Endocrine Rev. 2003; 24:737-764.
33. Yu C, Wang F, Jin C, Huang X, Miller DL, Basilico C, Mc- Keehan WL. Role of fibroblast growth factor type 1 and 2 in carbon tetrachloride-induced hepatic injury and fibrogensesis. Am J patho. 2003;163:1653-1662.
34. Shalitin N, Schlesinger H, Levy MJ, Kessler E, Kessler-Icekson G. Expression of procollagen C-proteinase enhancer in cultured rat heart fibroblasts: evidence for coregulation with type I collagen. J Cell Biochem. 2003;90:397-407.
35. Pennati G. Biomechanical properties of the human umbilical cord. Biorheology. 2001;38:355-366.
36. Macdonald AA, Colenbrander B, Wensing CJ. The effects of gestational age and chronic fetal decapitation on arterial blood pressure in the pig fetus. Eur J Obstet Gynecol Reprod Biol. 1983;16:63-70.
37. Stehbens WE, Wakefield JS, Gilbert-Barness F, Zuccollo JM. Histopathology and ultrastructure of human umbilical blood vessels. Fetal Pediatr pathol. 2005;2:297-315.
38. Terranova VP, DiFlorio R, Lyall RM, Hic S, Friesel R, Maciag T. Human endothelial cells are chemotactic to endothelial cell growth factor and heparin. J Cell Biol. 1985;101:2330-2334.
39. Stokes CL, Rupnick MA, Williams SK, Lauffenburger DA. Chemotaxis of human microvessel endothelial cells in response to acidic fibroblast growth factor. Lab Invest. 1990; 63:657-668.
40. Conway EM, Collen D, Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res. 2001;49:507-521.
41. Millette E, Rauch BH, Defawe O, Kenagy RD, Daum G, Clowes AW. Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation. Circ Res.2005;96:172-179.
42. Pintucci G, Yu PJ, Sharony R, Baumann FG, Saponara F, Frasca A, Galloway AC, Moscatelli D, Mignatti P. Induction of stromelysin-1 (MMP-3) by fibroblast growth factor-2 (FGF-2) in FGF-2-/- microvascular endothelial cells requires prolonged activation of extracellular signal-regulated kinases-1 and -2 (ERK-1/2). J Cell Biochem. 2003;90:1015-1025.
43. Mignatti P, Rifkin DB. Nonenzymatic interactions between proteinases and the cell surface: novel roles in normal and malignant cell physiology. Adv Cancer Res. 2000;78:103-157.
44. Murakami M, Nguyen LT, Zhang ZW, Moodie KL, Carmeliet P, Stan RV, Simons M. The FGF system has a key role in regulating vascular integrity. J Cli Invest. 2008;118:3355-3366.
45. Cao R, Eriksson A, Kubo H, Alitalo K, Cao Y, Thyberg J. Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-Cinduced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability. Circ Res. 2004;94:664-670.
46. Tash JA, David SG, Vaughan ED ED, Herzlinger DA. Fibroblast growth factor-7 regulates stratification of the bladder urothelium. J Urol. 2001;166:2536-2541.
47. Davis MA, Ireton RC, Reynolds AB. A core functions for p120-catenin in cadherin turnover. J Cell Biol. 2003;163: 525-534.
48. Ireton RC, Davis MA, van Hengel J, Mariner DJ, Barnes K, Thoreson MA, Anastasiadis PZ, Matrisian L, Bundy LM, Sealy L, Gilbert B, van Roy F, Reynolds AB. A novel role for p120 catenin in E-cadherin function. J Cell Biol. 2002;159: 465-476.
49. Yoshigi M, Clark EB, Yost H. Quantification of stretchinduced cytoskeletal remodeling in vascular endothelial cells by image processing. Cytometry. A 2003;55:109-118.
50. Haga JH, Li YS, Chien S. Molecular basis of the effects of mechanical stretch on vascular smooth muscle cells. J Biomech. 2007;40:947-960. Errata in: J Biomech. 2008;41:2331.